Stocktoria
VITASPRING BIOMEDICAL CO. LTD. VSBC
OTC · stock · Services-Commercial Physical & Biological Research · website · IPO 2019-10-01
VITASPRING BIOMEDICAL CO. LTD. financials (annual)
Bars are annual figures from 2017 to 2026; red bars are negative (a loss or cash outflow).
| Metric | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $5.6M | $248,200 | $15,140 | $17,180 | $16,230 | $0 |
| Gross profit | $0 | $0 | $0 | -$3.3M | $2.1M | $112,200 | $1,695 | $13,718 | $11,341 | $0 |
| SG&A expense | $385,411 | $679,914 | $1.1M | $844,836 | $941,336 | $537,582 | $21,181 | $36,114 | — | — |
| Operating income | -$385,411 | -$679,914 | -$1.1M | -$4.2M | $1.1M | $425,382 | $6,919 | -$22,396 | -$6,374 | — |
| Income tax | $29,957 | $95,008 | $0 | -$5,381 | $217,104 | $0 | $0 | $0 | — | — |
| Net income | -$415,368 | -$774,922 | -$1.1M | -$4.2M | $909,560 | $425,382 | $6,919 | -$22,396 | -$6,374 | -$45 |
| EPS (diluted) | $0.00 | $0.00 | $-0.01 | $-0.02 | $0.00 | — | — | — | — | — |
| Operating cash flow | -$2,688 | -$14,675 | -$34,920 | -$77,556 | -$269,631 | -$42,130 | $105 | -$34,248 | $401 | -$4,045 |
| Free cash flow | — | — | — | -$77,556 | -$342,628 | — | — | — | — | — |
| Cash & equivalents | — | $0 | $0 | — | $107,212 | $45,398 | $0 | $105 | $5,207 | $555 |
| Inventory | — | — | — | $0 | $0 | $144,000 | — | — | — | — |
| Total assets | $14,676 | $14,378 | $137,342 | $765,948 | $3.6M | $189,398 | $189,398 | $0 | $1,874 | $0 |
| Total liabilities | $4.4M | $4.0M | $3.5M | $3.2M | $2.0M | $93,034 | $96,364 | $11,431 | $12,891 | $4,555 |
| Shareholders' equity | -$4.4M | -$4.0M | -$3.4M | -$2.4M | $1.6M | $96,364 | $0 | -$6,919 | -$3,419 | $2,955 |
Growth · year-over-year
| Metric | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | — | — | — | -100.0% | +2161.6% | +1539.4% | -11.9% | +5.9% | — | — |
| Net income growth | — | — | — | -557.8% | +113.8% | +6048.0% | — | — | — | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2026-01-31. Facts plus Stocktoria's own computed scores — not investment advice.